tiprankstipranks
Vincerx Pharma announces two complete responses in VIP943 study
PremiumThe FlyVincerx Pharma announces two complete responses in VIP943 study
2M ago
Vincerx Pharma Announces Stock Option Repricing and Shareholder Approval
Premium
Company Announcements
Vincerx Pharma Announces Stock Option Repricing and Shareholder Approval
4M ago
Vincerx Pharma 6M share Spot Secondary priced at 75c
Premium
The Fly
Vincerx Pharma 6M share Spot Secondary priced at 75c
8M ago
Vincerx announces results from Phase 1 NIH-sponsored combo study of enitociclib
PremiumThe FlyVincerx announces results from Phase 1 NIH-sponsored combo study of enitociclib
12M ago
Vincerx Pharma presents preclinical VIP943, VIP924 posters at ASH 2023
Premium
The Fly
Vincerx Pharma presents preclinical VIP943, VIP924 posters at ASH 2023
1y ago
Cantor biotech/biopharma analysts hold analyst/industry conference call
Premium
The Fly
Cantor biotech/biopharma analysts hold analyst/industry conference call
1y ago
Vincerx Pharma doses first patient in Phase 1 trial evaluating VIP943
PremiumThe FlyVincerx Pharma doses first patient in Phase 1 trial evaluating VIP943
1y ago
Vincerx Pharma announces FDA clearance of IND for VIP943
Premium
The Fly
Vincerx Pharma announces FDA clearance of IND for VIP943
1y ago
Vincerx Pharma expects cash to fund operations into late 2024
Premium
The Fly
Vincerx Pharma expects cash to fund operations into late 2024
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100